CCR4 and cancer: SNX-482 was also shown to upregulate the expression of CCR4 (C-C motif chemokine receptor 4), IFNG (IFN-gamma), GZMB (granzyme B) and PDCD1 (programmed cell death protein 1) genes, which are important for anti-cancer activity.